Author/Creator: Strand, V - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Strand, V

1. 059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis. (12th April 2019)

Authors:: van Vollenhoven, R; Takeuchi, T; Pangan, A L; Friedman, A; Mohamed, M F; Chen, S; Rischmueller, M; Blanco, R; Xavier, R M; Strand, V
Journal:: Rheumatology
Issue:: Volume 58(2019)Supplement 3
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. SAT0126 Mental health benefits associated with reduction in disease activity among rheumatoid arthritis patients: a systematic review of the literature. (15th June 2017)

Authors:: Strand, V; Rendas-Baum, R; Kosinski, M; Brooks, D; Ganguly, R
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 816
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. AB0685 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with ankylosing spondylitis: long-term results from measure 1 and measure 2. (15th June 2017)

Authors:: Deodhar, A; Conaghan, PG; Strand, V; Boonen, A; Ferraccioli, G; Bosch, F Van den; Bhosekar, V; Porter, B; Gandhi, K; Jugl, S
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 1293
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. FRI0521 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with active psoriatic arthritis: 2-year results from future 1 and future 2. (15th June 2017)

Authors:: Strand, V; FitzGerald, O; Coates, LC; Walsh, JA; Cañete, JD; Bhosekar, V; Pricop, L; Gandhi, K; Jugl, S
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 688
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission. (15th June 2017)

Authors:: Smolen, JS; McInnes, IB; Gossec, L; Strand, V; Pricop, L; Fox, T; Jugl, S; Gaillez, C
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 1322
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide. Issue 01 (15th January 2009)

Authors:: Curtis, J R; Beukelman, T; Onofrei, A; Cassell, S; Greenberg, J D; Kavanaugh, A; Reed, G; Strand, V; Kremer, J M
Journal:: Annals of the rheumatic diseases
Issue:: Volume 69:Issue 01(2010)
Page Start:: 43
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. FRI0494 Secukinumab provides rapid and sustained pain relief in psoriatic arthritis: 2-year results from the future 2 study. (15th June 2017)

Authors:: McInnes, IB; Mease, PJ; Schett, G; Kirkham, B; Strand, V; Williams, N; Fox, T; Pricop, L; Jugl, S; Gandhi, KK
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 675
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. FRI0253 Patient-reported outcomes in patients with rheumatoid arthritis treated with subcutaneous tocilizumab compared with placebo or intravenous tocilizumab in combination with csdmards. (15th June 2017)

Authors:: Strand, V; Lampl, K; Birchwood, C; Pei, J; Tuckwell, K; Finch, R; Kivitz, A; Burmester, G
Journal:: Annals of the rheumatic diseases
Issue:: Volume 76(2017)Supplement 2
Page Start:: 581
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial. Issue 6 (17th November 2008)

Authors:: Smolen, J; Landewé, R B; Mease, P; Brzezicki, J; Mason, D; Luijtens, K; van Vollenhoven, R F; Kavanaugh, A; Schiff, M; Burmester, G R; Strand, V; Vencovský, J; van der Heijde, D
Journal:: Annals of the rheumatic diseases
Issue:: Volume 68:Issue 6(2009)
Page Start:: 797
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans. Issue 9 (4th January 2008)

Authors:: Singh, J A; Strand, V
Journal:: Annals of the rheumatic diseases
Issue:: Volume 67:Issue 9(2008)
Page Start:: 1310
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗